Idamycin PFS 1 mg/mL (Idarubicin Hydrochloride SOLUTION) 1 mg/mL

Idamycin PFS 1 mg/mL is an intravenous solution containing idarubicin hydrochloride, a chemotherapy agent. It is used in cancer treatment protocols. Learn about its uses, effects, and precautions.

Strength

1 mg/mL

Pack Size

1 VIAL, SINGLE-DOSE in 1 CARTON (0013-2576-05) / 5 mL in 1 VIAL, SINGLE-DOSE

Manufacturer / TM Owner

Pfizer Laboratories Div Pfizer Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Idamycin PFS 1 mg/mL is primarily used in the treatment of various types of cancer. It is often included in chemotherapy regimens to target cancer cells and inhibit their growth. The specific uses of idarubicin hydrochloride can vary depending on the type and stage of cancer being treated.

Side Effects

Common effects of Idamycin PFS 1 mg/mL may include nausea, vomiting, and fatigue. Some patients may experience hair loss or changes in blood cell counts. These effects can vary from person to person and should be discussed with a healthcare provider.

Precautions & Warnings

Idamycin PFS 1 mg/mL should be handled with care, as it is a potent chemotherapy agent. It is important to follow proper safety protocols when administering this medication. Patients should be monitored for any adverse reactions and should report any unusual symptoms to their healthcare provider.

Avoid Interactions

Idamycin PFS 1 mg/mL may interact with other medications, including those that affect the liver or bone marrow. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also interact with idarubicin hydrochloride.

References

Frequently Asked Questions

Idamycin PFS 1 mg/mL is used in the treatment of various types of cancer as part of chemotherapy regimens.

Idamycin PFS 1 mg/mL is administered intravenously by a healthcare professional in a clinical setting.

Common side effects may include nausea, vomiting, fatigue, and hair loss. Always consult a healthcare provider for personalized advice.

Idamycin PFS 1 mg/mL may interact with other medications, so it is important to discuss all current medications with a healthcare provider.

Precautions include following proper safety protocols during administration and monitoring for adverse reactions. Always consult a healthcare provider for guidance.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.